The Antioxidant Debate

Explore: The Journal of Science and Healing

Volumn 6, Issue 2, 2010, Pages 75-85

  Ladas, Elena ^a   Kelly, Kara M ^a  

^a NewYork Presbyterian Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTHRACYCLINE; ANTINEOPLASTIC AGENT; ANTIOXIDANT; ARSENIC TRIOXIDE; ASCORBIC ACID; BETA CAROTENE; CISPLATIN; ETOPOSIDE; FLUOROURACIL; FOLIC ACID; INTERFERON; IRINOTECAN; LYCOPENE; MELATONIN; MELPHALAN; MULTIVITAMIN; NIFEDIPINE; PACLITAXEL; PENTOXIFYLLINE; PLACEBO; PROANTHOCYANIDIN; RETINOL; SELENIUM; TAMOXIFEN; THIOCTIC ACID; UBIDECARENONE; VINCA ALKALOID;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADVANCED CANCER; ANEMIA; ANTIOXIDANT ACTIVITY; ARTICLE; BONE MARROW SUPPRESSION; BONE MARROW TOXICITY; BREAST CANCER; CACHEXIA; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER SURVIVAL; CARDIOMYOPATHY; CARDIOTOXICITY; CHILDHOOD CANCER; CLINICAL TRIAL; COLORECTAL CANCER; DIGESTIVE SYSTEM CANCER; DOSE RESPONSE; DRUG ABSORPTION; DRUG ACTIVITY; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CLASSIFICATION; DRUG CYTOTOXICITY; DRUG DOSAGE FORM COMPARISON; DRUG EFFECT; DRUG EFFICACY; DRUG MEGADOSE; DRUG POTENTIATION; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; ENTERITIS; ESOPHAGUS CANCER; HEAD AND NECK CANCER; HEART LEFT VENTRICLE FAILURE; HUMAN; HYPERTRIGLYCERIDEMIA; KIDNEY CARCINOMA; LUNG CANCER; LUNG NON SMALL CELL CANCER; MALIGNANT NEOPLASTIC DISEASE; METASTASIS; MONOTHERAPY; MUCOSA INFLAMMATION; MULTIPLE MYELOMA; NEOPLASM; NEPHROTOXICITY; NEUROPATHY; NEUROTOXICITY; NONHODGKIN LYMPHOMA; OTOTOXICITY; OVARY CANCER; OXIDATIVE STRESS; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROCTITIS; PROSTATE CANCER; SKIN INDURATION; SOLID TUMOR; TREATMENT CONTRAINDICATION; UNSPECIFIED SIDE EFFECT;

ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; CHEMOTHERAPY, ADJUVANT; DIETARY SUPPLEMENTS; DISSENT AND DISPUTES; HUMANS; NEOPLASMS;

EID: 77949981998     PISSN: 15508307     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.explore.2009.12.008     Document Type: Article

References (92)

1. Block K.I., Koch A.C., Mead M.N., Tothy P.K., Newman R.A., and Gyllenhaal C. Impact of antioxidant supplementation on chemotherapeutic efficacy: a systematic review of the evidence from randomized controlled trials. Cancer Treat Rev 33 (2007) 407-418
2. Branda R.F., Naud S.J., Brooks E.M., Chen Z., and Muss H. Effect of vitamin B12, folate, and dietary supplements on breast carcinoma chemotherapy-induced mucositis and neutropenia. Cancer 101 (2004) 1058-1064
3. Burstein H.J., Gelber S., Guadagnoli E., and Weeks J.C. Use of alternative medicine by women with early-stage breast cancer. N Engl J Med 340 (1999) 1733-1739
4. Clemens M.R., Waladkhani A.R., Bublitz K., Ehninger G., and Gey K.F. Supplementation with antioxidants prior to bone marrow transplantation. Wien Klin Wochenschr 109 (1997) 771-776
5. Kelly K.M., Jacobson J.S., Kennedy D.D., Braudt S.M., Mallick M., and Weiner M.A. Use of unconventional therapies by children with cancer at an urban medical center. J Pediatr Hematol Oncol 22 (2000) 412-416
6. Legha S., Wang Y., Mackay B., et al. Clinical and pharmacologic investigation of the effects of alpha-tocopherol on adriamycin cardiotoxicity. Ann N Y Acad Sci 393 (1982) 411-418
7. Lesperance M.L., Olivotto I.A., Forde N., et al. Mega-dose vitamins and minerals in the treatment of non-metastatic breast cancer: an historical cohort study. Breast Cancer Res Treat 76 (2002) 137-143
8. Rock C.L., Newman V.A., Neuhouser M.L., Major J., and Barnett M.J. Antioxidant supplement use in cancer survivors and the general population. J Nutr 134 (2004) 3194S-3195S
9. Ratnam D.V., Ankola D.D., Bhardwaj V., Sahana D.K., and Kumar M.N. Role of antioxidants in prophylaxis and therapy: a pharmaceutical perspective. J Control Release 20 113 (2006) 189-207
10. Salganik R.I., Albright C.D., Rodgers J., et al. Dietary antioxidant depletion: enhancement of tumor apoptosis and inhibition of brain tumor growth in transgenic mice. Carcinogenesis 21 (2000) 909-914
11. Mannisto S., Smith-Warner S.A., Spiegelman D., et al. Dietary carotenoids and risk of lung cancer in a pooled analysis of seven cohort studies. Cancer Epidemiol Biomarkers Prev 13 (2004) 40-48
12. Yong L.C., Brown C.C., Schatzkin A., et al. Intake of vitamins E, C, and A and risk of lung cancer. The NHANES I epidemiologic followup study. First National Health and Nutrition Examination Survey. Am J Epidemiol 146 (1997) 231-243
13. Mark S.D., Qiao Y.L., Dawsey S.M., et al. Prospective study of serum selenium levels and incident esophageal and gastric cancers. J Natl Cancer Inst 92 (2000) 1753-1763
14. Bjelakovic G., Nikolova D., Simonetti R.G., and Gluud C. Antioxidant supplements for preventing gastrointestinal cancers. Cochrane Database Syst Rev 4 (2004) CD004183
15. Jenab M., Riboli E., Ferrari P., et al. Plasma and dietary carotenoid, retinol and tocopherol levels and the risk of gastric adenocarcinomas in the European prospective investigation into cancer and nutrition. Br J Cancer 95 (2006) 406-415
16. Jenab M., Riboli E., Ferrari P., et al. Plasma and dietary vitamin C levels and risk of gastric cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST). Carcinogenesis 27 (2006) 2250-2257
17. Moss R.W. Should patients undergoing chemotherapy and radiotherapy be prescribed antioxidants?. Integr Cancer Ther 5 (2006) 63-82
18. Durken M., Herrnring C., Finckh B., et al. Impaired plasma antioxidative defense and increased nontransferrin-bound iron during high-dose chemotherapy and radiochemotherapy preceding bone marrow transplantation. Free Radic Biol Med 28 (2000) 887-894
19. Kennedy D.D., Ladas E.J., Rheingold S.R., Blumberg J., and Kelly K.M. Antioxidant status decreases in children with acute lymphoblastic leukemia during the first six months of chemotherapy treatment. Pediatr Blood Cancer 44 (2004) 378-385
20. Kennedy D., Tucker K., Ladas E.J., et al. Low antioxidant vitamin intakes are associated with increases in adverse effects of chemotherapy in children with acute lymphoblastic leukemia. American Journal of Clinical Nutrition 79 (2004) 1029-1036
21. Creagan E.T., Moertel C.G., O'Fallon J.R., et al. Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer. A controlled trial. N Engl J Med 301 (1979) 687-690
22. Culy C., and Spencer C. Amifostine: an update on its clinical status as a cytoprotectant in patients with cancer receiving chemotherapy or radiotherapy and its potential therapeutic application in myelodysplastic syndrome. Drugs 61 (2001) 641-684
23. McEvoy G.K. AHFS 2002 Drug Information (2002), American Society of Health-System Pharmacists, Inc, Bethesda, Maryland
24. Moertel C.G., Fleming T.R., Creagan E.T., Rubin J., O'Connell M.J., and Ames M.M. High-dose vitamin C versus placebo in the treatment of patients with advanced cancer who have had no prior chemotherapy. A randomized double-blind comparison. N Engl J Med 312 (1985) 137-141
25. Bairati I., Meyer F., Jobin E., et al. Antioxidant vitamins supplementation and mortality: A randomized trial in head and neck cancer patients. International Journal of Cancer 119 (2006) 2221-2224
26. Drisko J.A., Chapman J., and Hunter V.J. The use of antioxidant therapies during chemotherapy. Gynecol Oncol 88 (2003) 434-439
27. Drisko J.A., Chapman J., and Hunter V.J. The use of antioxidants with first-line chemotherapy in two cases of ovarian cancer. J Am Coll Nutr 22 (2003) 118-123
28. Hoenjet K.M., Dagnelie P.C., Delaere K.P., Wijckmans N.E., Zambon J.V., and Oosterhof G.O. Effect of a nutritional supplement containing vitamin E, selenium, vitamin c and coenzyme Q10 on serum PSA in patients with hormonally untreated carcinoma of the prostate: a randomised placebo-controlled study. Eur Urol 47 (2005) 433-439
29. Ladas E.J., Jacobson J.S., Kennedy D.D., Teel K., Fleischauer A., and Kelly K.M. Antioxidants and cancer therapy: a systematic review. J Clin Oncol 22 (2004) 517-528
30. Pathak A.K., Bhutani M., Guleria R., et al. Chemotherapy Alone vs. Chemotherapy Plus High Dose Multiple Antioxidants in Patients with Advanced Non Small Cell Lung Cancer. J Am Coll Nutr 24 (2005) 16-21
31. Simone C.B., Simone N.L., Simone V., and Simone C.B. Antioxidants and other nutrients do not interfere with chemotherapy or radiation therapy and can increase kill and increase survival, part 1. Altern Ther Health Med 13 (2007) 22-28
32. Simone C.B., Simone N.L., Simone V., and Simone C.B. Antioxidants and other nutrients do not interfere with chemotherapy or radiation therapy and can increase kill and increase survival, Part 2. Altern Ther Health Med 13 (2007) 40-47
33. Papas A.M. Antioxidant Status, Diet, Nutrition, and Health (1999), CRC Press, Boca Raton
34. Padayatty S.J., Sun H., Wang Y., et al. Vitamin C pharmacokinetics: implications for oral and intravenous use. Ann Intern Med 140 (2004) 533-537
35. Ambrosone C.B., Ahn J., Singh K.K., et al. Polymorphisms in genes related to oxidative stress (MPO, MnSOD, CAT) and survival after treatment for breast cancer. Cancer Res 65 (2005) 1105-1111
36. Davies S.M., Robison L.L., Buckley J.D., et al. Glutathione S-transferase polymorphisms and outcome of chemotherapy in childhood acute myeloid leukemia. J Clin Oncol 19 (2001) 1279-1287
37. Jaakkola K., Lahteenmaki P., Laakso J., Harju E., Tykka H., and Mahlberg K. Treatment with antioxidant and other nutrients in combination with chemotherapy and irradiation in patients with small-cell lung cancer. Anticancer Res 12 (1992) 599-606
38. Lockwood K., Moesgaard S., Hanioka T., and Folkers K. Apparent partial remission of breast cancer in 'high risk' patients supplemented with nutritional antioxidants, essential fatty acids and coenzyme Q10. Mol Aspects Med 15Suppl (1994) s231-s240
39. Lamm D.L., Riggs D.R., Shriver J.S., vanGilder P.F., Rach J.F., and DeHaven J.I. Megadose vitamins in bladder cancer: a double-blind clinical trial. J Urol 151 (1994) 21-26
40. Mills E.E. The modifying effect of beta-carotene on radiation and chemotherapy induced oral mucositis. Br J Cancer 57 (1988) 416-417
41. Cameron E., Pauling L., and Leibovitz B. Ascorbic acid and cancer: review. Cancer Res 39 (1979) 663-681
42. Wittes R.E. Vitamin C and cancer. N Engl J Med 312 (1985) 178-179
43. Cameron E., and Pauling L. Supplemental ascorbate in the supportive treatment of cancer: Prolongation of survival times in terminal human cancer. Proc Natl Acad Sci U S A 73 (1976) 3685-3689
44. Cameron E., and Pauling L. Supplemental ascorbate in the supportive treatment of cancer: reevaluation of prolongation of survival times in terminal human cancer. Proc Natl Acad Sci U S A 75 (1978) 4538-4542
45. Cameron E. Protocol for the use of vitamin C in the treatment of cancer. Med Hypotheses 36 (1991) 190-194
46. Koh W.S., Lee S.J., Lee H., et al. Differential effects and transport kinetics of ascorbate derivatives in leukemic cell lines. Anticancer Res 4A (1998) 2487-2493
47. Padayatty S.J., Riordan H.D., Hewitt S.M., Katz A., Hoffer L.J., and Levine M. Intravenously administered vitamin C as cancer therapy: three cases. CMAJ 174 (2006) 937-942
48. Berenson J.R., Boccia R., Siegel D., et al. Efficacy and safety of melphalan, arsenic trioxide and ascorbic acid combination therapy in patients with relapsed or refractory multiple myeloma: a prospective, multicentre, phase II, single-arm study. Br J Haematol 135 (2006) 174-183
49. Hardeland R. Antioxidative protection by melatonin: multiplicity of mechanisms from radical detoxification to radical avoidance. Endocrine 27 (2005) 119-130
50. Lissoni P. Is there a role for melatonin in supportive care?. Support Care Cancer 10 (2002) 110-116
51. Mahmoud F., Sarhill N., and Mazurczak M.A. The therapeutic application of melatonin in supportive care and palliative medicine. Am J Hosp Palliat Care 22 (2005) 295-309
52. Mills E., Wu P., Seely D., and Guyatt G. Melatonin in the treatment of cancer: a systematic review of randomized controlled trials and meta-analysis. J Pineal Res 39 (2005) 360-366
53. Neri B., Fiorelli C., Moroni F., et al. Modulation of human lymphoblastoid interferon activity by melatonin in metastatic renal cell carcinoma. A phase II study. Cancer 73 (1994) 3015-3019
54. Lissoni P., Chilelli M., Villa S., Cerizza L., and Tancini G. Five years survival in metastatic non-small cell lung cancer patients treated with chemotherapy alone or chemotherapy and melatonin: a randomized trial. J Pineal Res 35 (2003) 12-15
55. Cerea G., Vaghi M., Ardizzoia A., et al. Biomodulation of cancer chemotherapy for metastatic colorectal cancer: a randomized study of weekly low-dose irinotecan alone versus irinotecan plus the oncostatic pineal hormone melatonin in metastatic colorectal cancer patients progressing on 5-fluorouracil-containing combinations. Anticancer Res 23 (2003) 1951-1954
56. Mantovani G., Maccio A., Madeddu C., et al. A phase II study with antioxidants, both in the diet and supplemented, pharmaconutritional support, progestagen, and anti-cyclooxygenase-2 showing efficacy and safety in patients with cancer-related anorexia/cachexia and oxidative stress. Cancer Epidemiol Biomarkers Prev 15 (2006) 1030-1034
57. Iarussi D., Auricchio U., Agretto A., et al. Protective effect of coenzyme Q10 on anthracyclines cardiotoxicity: control study in children with acute lymphoblastic leukemia and non-Hodgkin lymphoma. Mol Aspects Med 15Suppl (1994) s207-s212
58. Okuma K., Furuta I., and Ota K. Protective effect of coenzyme Q10 in cardiotoxicity induced by adriamycin. Gan To Kagaku Ryoho 11 (1984) 502-508
59. Takimoto M., Sakurai T., Kodama K., et al. Protective effect of CoQ 10 administration on cardial toxicity in FAC therapy. Gan To Kagaku Ryoho 9 (1982) 116-121
60. Lenzhofer R., Ganzinger U., Rameis H., and Moser K. Acute cardiac toxicity in patients after doxorubicin treatment and the effect of combined tocopherol and nifedipine pretreatment. J Cancer Res Clin Oncol 106 (1983) 143-147
61. Wagdi P., Fluri M., Aeschbacher B., Fikrle A., and Meier B. Cardioprotection in patients undergoing chemo- and/or radiotherapy for neoplastic disease. A pilot study. Jpn Heart J 37 (1996) 353-359
62. Weitzman S.S., Lorell B., Carey R.W., Kaufman S., and Stossel T.P. Prospective study of tocopherol prophylaxis for anthracycline cardiac toxicity. Current Therapeutic Research 28 (1980) 682-686
63. Argyriou A.A., Chroni E., Koutras A., et al. Vitamin E for prophylaxis against chemotherapy-induced neuropathy: a randomized controlled trial. Neurology 64 (2005) 26-31
64. Argyriou A.A., Chroni E., Koutras A., et al. Preventing paclitaxel-induced peripheral neuropathy: a phase II trial of vitamin E supplementation. J Pain Symptom Manage 32 3 (2006) 237-244
65. Weijl N.I., Elsendoorn T.J., Lentjes E.G., et al. Supplementation with antioxidant micronutrients and chemotherapy-induced toxicity in cancer patients treated with cisplatin-based chemotherapy: a randomised, double-blind, placebo-controlled study. Eur J Cancer 40 11 (2004) 1713-1723
66. Sieja K. Protective role of selenium against the toxicity of multi-drug chemotherapy in patients with ovarian cancer. Pharmazie 55 (2000) 958-959
67. Hu Y.J., Chen Y., Zhang Y.Q., et al. The protective role of selenium on the toxicity of cisplatin-contained chemotherapy regimen in cancer patients. Biol Trace Elem Res 56 (1997) 331-341
68. Blanke C.D., Stipanov M., Morrow J., et al. A phase I study of vitamin E, 5-fluorouracil and leucovorin for advanced malignancies. Invest New Drugs 19 (2001) 21-27
69. Babu J.R., Sundravel S., Arumugam G., Renuka R., Deepa N., and Sachdanandam P. Salubrious effect of vitamin C and vitamin E on tamoxifen-treated women in breast cancer with reference to plasma lipid and lipoprotein levels. Cancer Lett 151 (2000) 1-5
70. Hille A., Christiansen H., Pradier O., et al. Effect of pentoxifylline and tocopherol on radiation proctitis/enteritis. Strahlenther Onkol 181 (2005) 606-614
71. Brooker S., Martin S., Pearson A., et al. Double-blind, placebo-controlled, randomised phase II trial of IH636 grape seed proanthocyanidin extract (GSPE) in patients with radiation-induced breast induration. Radiother Oncol 79 (2006) 45-51
72. Wadleigh R.G., Redman R.S., Graham M.L., Krasnow S.H., Anderson A., and Cohen M.H. Vitamin E in the treatment of chemotherapy-induced mucositis. Am J Med 92 (1992) 481-484
73. Ferreira P.R., Fleck J.F., Diehl A., et al. Protective effect of alpha-tocopherol in head and neck cancer radiation-induced mucositis: a double-blind randomized trial. Head Neck 26 (2004) 313-321
74. Bairati I., Meyer F., Jobin E., et al. Antioxidant vitamins supplementation and mortality: a randomized trial in head and neck cancer patients. International Journal of Cancer 119 (2006) 2221-2224
75. Misirlioglu C.H., Erkal H., Elgin Y., Ugur I., and Altundag K. Effect of concomitant use of pentoxifylline and alpha-tocopherol with radiotherapy on the clinical outcome of patients with stage IIIB non-small cell lung cancer: a randomized prospective clinical trial. Med Oncol 23 (2006) 185-189
76. ®, a Nutraceutical Cysteine Delivery Agent in the Management of Wasting in High-Risk Childhood Cancer Patients. 1st Annual Chicago Supportive Oncology Conference. October 6-8, 2005.
77. Letur-Könirsch H., Guis F., Delanian S., et al. Uterine restoration by radiation sequelae regression with combined pentoxifylline-tocopherol: a phase II study. Fertil Steril 77 (2002) 1219-1226
78. Langer C.J., Hoffman J.P., and Ottery F.D. Clinical significance of weight loss in cancer patients: rationale for the use of anabolic agents in the treatment of cancer-related cachexia. Nutrition 17 1 Suppl (2001) S1-S20
79. Pacheo L., Goldhart J., Guilford T., Kwyer T., and Kongshavn P. Cysteine-Rich Dietary Supplement Alleviates Gastrointestinal Side-Effects with Associated Weight Gain and Marked Improvement in HAART Adherence in AIDS Patients. Journal of Human Virology 5 (1997) 90
80. Greenberg S., and Frishman W.H. Co-enzyme Q10: a new drug for cardiovascular disease. J Clin Pharmacol 30 (1990) 596-608
81. Folkers K., Osterborg A., Nylander M., Morita M., and Mellstedt H. Activities of vitamin Q10 in animal models and a serious deficiency in patients with cancer. Biochem Biophys Res Commun 234 (1997) 296-299
82. Rusciani L., Proietti I., Rusciani A., et al. Low plasma coenzyme Q10 levels as an independent prognostic factor for melanoma progression. J Am Acad Dermatol 54 (2006) 234-241
83. Shinkai T., Tominaga K., Shimabukuro Z., et al. [Platelet aggregation and coenzyme Q10 content in platelets in cancer patients]. Gan To Kagaku Ryoho 11 (1984) 87-96
84. Roffe L., Schmidt K., and Ernst E. Efficacy of coenzyme Q10 for improved tolerability of cancer treatments: a systematic review. J Clin Oncol 22 (2004) 4418-4424
85. Weijl N.I., Hopman G.D., Wipkink-Bakker A., et al. Cisplatin combination chemotherapy induces a fall in plasma antioxidants of cancer patients. Ann Oncol 9 (1998) 1331-1337
86. Leonetti C., Biroccio A., Gabellini C., et al. Alpha-tocopherol protects against cisplatin-induced toxicity without interfering with antitumor efficacy. Int J Cancer 20 104 (2003) 243-250
87. Ravi R., Somani S.M., and Rybak L.P. Mechanism of cisplatin ototoxicity: antioxidant system. Pharmacol Toxicol 76 (1995) 386-394
88. Sieja K. Protective role of selenium against the toxicity of multi-drug chemotherapy in patients with ovarian cancer. Pharmazie 55 (2000) 958-959
89. Omenn G.S., Goodman G.E., Thornquist M.D., et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 334 (1996) 1150-1155
90. Prasad K.N., and Cole W.C. Antioxidants in cancer therapy. J Clin Oncol 20 (2006) e8-e9
91. Seely D., Stempak D., and Baruchel S. A strategy for controlling potential interactions between natural health products and chemotherapy: a review in pediatric oncology. J Pediatr Hematol Oncol 29 (2007) 32-47
92. Weiger W.A., Smith M., Boon H., Richardson M.A., Kaptchuk T.J., and Eisenberg D.M. Advising patients who seek complementary and alternative medical therapies for cancer. Ann Intern Med 137 (2002) 889-903